FDA Inspection 1111913 — Fareez Mohamed, MD

Fareez Mohamed, MD — FEI 3015494733

The FDA completed an inspection of Fareez Mohamed, MD on October 31, 2019 in Basingstoke. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 31, 2019
Fiscal Year
2020
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Basingstoke (United Kingdom)

Additional Details

Clinical Investigator (CI)